Charles Schwab’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-337,671
| Closed | -$6M | – | 3156 |
|
|
2018
Q3 | $6M | Buy |
337,671
+198,971
| +143% | +$3.53M | ﹤0.01% | 1947 |
|
|
2018
Q2 | $1.92M | Buy |
138,700
+127,400
| +1,127% | +$1.76M | ﹤0.01% | 2393 |
|
|
2018
Q1 | $103K | Hold |
11,300
| – | – | ﹤0.01% | 3036 |
|
|
2017
Q4 | $49K | Hold |
11,300
| – | – | ﹤0.01% | 3050 |
|
|
2017
Q3 | $16K | Sell |
11,300
-54,451
| -83% | -$77.1K | ﹤0.01% | 3074 |
|
|
2017
Q2 | $99K | Sell |
65,751
-49,792
| -43% | -$75K | ﹤0.01% | 3079 |
|
|
2017
Q1 | $297K | Buy |
115,543
+5,472
| +5% | +$14.1K | ﹤0.01% | 2823 |
|
|
2016
Q4 | $281K | Buy |
110,071
+37,728
| +52% | +$96.3K | ﹤0.01% | 2866 |
|
|
2016
Q3 | $224K | Sell |
72,343
-39,890
| -36% | -$124K | ﹤0.01% | 2888 |
|
|
2016
Q2 | $361K | Buy |
112,233
+1,680
| +2% | +$5.4K | ﹤0.01% | 2712 |
|
|
2016
Q1 | $343K | Buy |
110,553
+2,040
| +2% | +$6.33K | ﹤0.01% | 2724 |
|
|
2015
Q4 | $436K | Buy |
108,513
+2,600
| +2% | +$10.4K | ﹤0.01% | 2704 |
|
|
2015
Q3 | $486K | Sell |
105,913
-37,229
| -26% | -$171K | ﹤0.01% | 2636 |
|
|
2015
Q2 | $743K | Buy |
143,142
+4,023
| +3% | +$20.9K | ﹤0.01% | 2536 |
|
|
2015
Q1 | $871K | Buy |
139,119
+47,170
| +51% | +$295K | ﹤0.01% | 2420 |
|
|
2014
Q4 | $579K | Buy |
91,949
+2,196
| +2% | +$13.8K | ﹤0.01% | 2562 |
|
|
2014
Q3 | $546K | Buy |
89,753
+1,729
| +2% | +$10.5K | ﹤0.01% | 2552 |
|
|
2014
Q2 | $581K | Sell |
88,024
-544
| -0.6% | -$3.59K | ﹤0.01% | 2559 |
|
|
2014
Q1 | $2.11M | Buy |
88,568
+11,840
| +15% | +$282K | ﹤0.01% | 1930 |
|
|
2013
Q4 | $821K | Buy |
76,728
+2,448
| +3% | +$26.2K | ﹤0.01% | 2361 |
|
|
2013
Q3 | $1.02M | Buy |
74,280
+3,298
| +5% | +$45.5K | ﹤0.01% | 2203 |
|
|
2013
Q2 | $979K | Buy |
+70,982
| New | +$979K | ﹤0.01% | 2174 |
|